4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Influence of ABCB-1, ERCC-1 and ERCC-2 gene polymorphisms on response to capecitabine and oxaliplatin (CAPOX) treatment in colorectal cancer (CRC) patients of South India.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          High interindividual response variability was reported with capecitabine and oxaliplatin (CAPOX) regimen in colorectal cancer (CRC). The single nucleotide polymorphisms (SNPs) of the genes related to drug efflux transport (ABCB1) and DNA repair (ERCC) could result in altered tumour response. Hence, this study was designed to assess the influence of ABCB1, ERCC-1 and ERCC-2 gene polymorphisms on tumour response to CAPOX treatment in CRC patients of South Indian origin.

          Related collections

          Author and article information

          Journal
          J Clin Pharm Ther
          Journal of clinical pharmacy and therapeutics
          Wiley
          1365-2710
          0269-4727
          Aug 2020
          : 45
          : 4
          Affiliations
          [1 ] Pharmacology Department, JIPMER, Puducherry, India.
          [2 ] Regional Cancer Centre, JIPMER, Puducherry, India.
          Article
          10.1111/jcpt.13166
          32399998
          641ac2c0-3bcc-45f8-8998-74635a02b2c4
          History

          response variations,ATP-binding cassette family B member 1 (ABCB1),CAPOX regimen,P-glycoprotein,excision repair cross-complementing protein (ERCC),single nucleotide polymorphisms

          Comments

          Comment on this article